Loading...
XNYSTDOC
Market cap1.70bUSD
Jan 10, Last price  
9.87USD
1D
0.92%
1Q
7.28%
Jan 2017
-40.18%
IPO
-64.75%
Name

Teladoc Health Inc

Chart & Performance

D1W1MN
XNYS:TDOC chart
P/E
—
P/S
0.65
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
20.11%
Rev. gr., 5y
44.16%
Revenues
2.60b
+8.13%
19,906,00043,528,00077,384,000123,157,000233,279,000417,907,000553,307,0001,093,962,0002,032,707,0002,406,840,0002,602,415,000
Net income
-220m
L-98.39%
-6,019,000-17,037,000-58,020,000-74,216,000-106,782,000-97,084,000-98,864,000-485,136,000-428,793,000-13,659,531,000-220,368,000
CFO
350m
+84.91%
-6,053,000-11,359,000-47,181,000-51,795,000-34,441,000-4,860,00029,869,000-53,511,000193,990,000189,292,000350,021,000
Earnings
Feb 18, 2025

Profile

Teladoc Health, Inc. provides virtual healthcare services in the United States and internationally. The company offers a portfolio of services and solutions covering non-urgent, episodic, chronic, and complicated medical conditions, including diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure, and mental health conditions. It offers a range of programs and services, including primary and specialty care telehealth solutions, chronic condition management, expert medical services, mental health solutions, and platform and program services. The company serves employers, health plans, hospitals and health systems, and insurance and financial services companies, as well as individual members. It offers its products and services under the Teladoc, Livongo, and BetterHelp brands. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. The company was incorporated in 2002 and is headquartered in Purchase, New York.
URL
https://www.teladochealth.com/
IPO date
Jul 01, 2015
Employees
4,816
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
2,602,415
8.13%
2,406,840
18.41%
Cost of revenue
2,475,845
2,378,179
Unusual Expense (Income)
NOPBT
126,570
28,661
NOPBT Margin
4.86%
1.19%
Operating Taxes
760
(3,812)
Tax Rate
0.60%
NOPAT
125,810
32,473
Net income
(220,368)
-98.39%
(13,659,531)
3,085.58%
Dividends
Dividend yield
Proceeds from repurchase of equity
10,854
5,884
BB yield
-0.31%
-0.15%
Debt
Debt current
10,752
13,592
Long-term debt
1,635,114
1,611,372
Deferred revenue
13,623
3,872
Other long-term liabilities
1,080
9,700
Net debt
522,191
1,062,382
Cash flow
Cash from operating activities
350,021
189,292
CAPEX
(156,348)
(172,764)
Cash from investing activities
(156,347)
(167,743)
Cash from financing activities
10,854
6,497
FCF
136,219
35,082
Balance
Cash
1,123,675
918,182
Long term investments
(355,600)
Excess cash
993,554
442,240
Stockholders' equity
(15,265,478)
(15,050,900)
Invested Capital
19,198,531
18,945,139
ROIC
0.66%
0.17%
ROCE
3.18%
0.73%
EV
Common stock shares outstanding
164,578
161,457
Price
21.55
-8.88%
23.65
-74.24%
Market cap
3,546,661
-7.12%
3,818,461
-73.50%
EV
4,068,852
4,880,843
EBITDA
477,893
299,304
EV/EBITDA
8.51
16.31
Interest
22,282
9,270
Interest/NOPBT
17.60%
32.34%